These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


414 related items for PubMed ID: 24432803

  • 1. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B.
    Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
    [Abstract] [Full Text] [Related]

  • 2. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C.
    Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 4. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 5. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.
    Eur Heart J; 2013 Jul 12; 34(28):2114-21. PubMed ID: 23786861
    [Abstract] [Full Text] [Related]

  • 6. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC, ICV-GVM la Roseraie.
    Ann Cardiol Angeiol (Paris); 2013 Dec 12; 62(6):384-91. PubMed ID: 24182849
    [Abstract] [Full Text] [Related]

  • 7. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S, Ormiston J, Bergmann MW, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A.
    EuroIntervention; 2015 Feb 12; 10(10):1221-9. PubMed ID: 25452198
    [Abstract] [Full Text] [Related]

  • 8. Impact of Renal Sympathetic Denervation on Left Ventricular Structure and Function at 1-Year Follow-Up.
    de Sousa Almeida M, de Araújo Gonçalves P, Branco P, Mesquita J, Carvalho MS, Dores H, Silva Sousa H, Gaspar A, Horta E, Aleixo A, Neuparth N, Mendes M, Andrade MJ.
    PLoS One; 2016 Feb 12; 11(3):e0149855. PubMed ID: 26934735
    [Abstract] [Full Text] [Related]

  • 9. Blood pressure and neurohormonal responses to renal nerve ablation in treatment-resistant hypertension.
    Ezzahti M, Moelker A, Friesema EC, van der Linde NA, Krestin GP, van den Meiracker AH.
    J Hypertens; 2014 Jan 12; 32(1):135-41. PubMed ID: 24131897
    [Abstract] [Full Text] [Related]

  • 10. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.
    EuroIntervention; 2012 Jan 12; 7(9):1077-80. PubMed ID: 21959556
    [Abstract] [Full Text] [Related]

  • 11. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 12; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 12. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 12; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 13. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2015 Dec 12; 104(12):1097-105. PubMed ID: 26306594
    [Abstract] [Full Text] [Related]

  • 14. Renal denervation: results of a single-center cohort study.
    Luetkens JA, Wilhelm K, Düsing R, Woitas RP, Thomas D, Hundt F, Doerner J, Schild HH, Nähle CP.
    Rofo; 2015 Jan 12; 187(1):36-41. PubMed ID: 25188311
    [Abstract] [Full Text] [Related]

  • 15. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2014 Sep 16; 64(11):1071-8. PubMed ID: 24858423
    [Abstract] [Full Text] [Related]

  • 16. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension).
    Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B, Courand PY, Delsart P, Denolle T, Dourmap C, Ferrari E, Girerd X, Michel Halimi J, Herpin D, Lantelme P, Monge M, Mounier-Vehier C, Mourad JJ, Ormezzano O, Ribstein J, Rossignol P, Sapoval M, Vaïsse B, Zannad F, Azizi M.
    Hypertension; 2017 Mar 16; 69(3):494-500. PubMed ID: 28115517
    [Abstract] [Full Text] [Related]

  • 17. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A.
    J Hypertens; 2016 Aug 16; 34(8):1639-47. PubMed ID: 27228432
    [Abstract] [Full Text] [Related]

  • 18. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, Piñeiro L, Ríos MT, Otero A, Balan H, Fernández JR.
    Clin Investig Arterioscler; 2013 Aug 16; 25(2):74-82. PubMed ID: 23849214
    [Abstract] [Full Text] [Related]

  • 19. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
    Lambert T, Nahler A, Reiter C, Gammer V, Blessberger H, Kammler J, Grund M, Saleh K, Schwarz S, Steinwender C.
    Catheter Cardiovasc Interv; 2015 Sep 16; 86(3):E126-30. PubMed ID: 26033366
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT, Domínguez-Sardiña M, Ayala DE, Gomara S, Sineiro E, Pousa L, Callejas PA, Fontao MJ, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar 16; 30(1-2):207-20. PubMed ID: 23077975
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.